SEC Filings

8-K
MEDTRONIC PLC filed this Form 8-K on 12/19/2017
Entire Document
 
Exhibit


http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=11945877&doc=3
 
Exhibit 99.1
  
NEWS RELEASE


 
 
 
 
 
 
 
Contacts:
  
 
 
 
 
 
 
 
 
Fernando Vivanco
  
Ryan Weispfenning
 
 
Public Relations
  
Investor Relations
 
 
+1-763-505-3780
  
+1-763-505-4626


FOR IMMEDIATE RELEASE

BOB WHITE NAMED EXECUTIVE VICE PRESIDENT AND
PRESIDENT OF MEDTRONIC’S MINIMALLY INVASIVE THERAPIES GROUP;
CHRIS LEE TO ASSUME LEADERSHIP OF MEDTRONIC’S ASIA PACIFIC REGION

Bryan Hanson Leaves Medtronic to Become President and CEO of a Public Company

DUBLIN - December 19, 2017 - Medtronic plc (NYSE: MDT) announced today that Bob White, previously Senior Vice President and President of Medtronic’s Asia Pacific (APAC) Region, has been named Executive Vice President and President of Medtronic’s Minimally Invasive Therapies Group (MITG). In addition, the company announced that Chris Lee, Senior Vice President and President of Medtronic’s Greater China Region, will assume the position of APAC Region President. Lee will remain the Interim President of the Greater China Region until a permanent successor is named in the coming weeks. These leadership changes are effective immediately.

The leadership changes are a result of Bryan Hanson’s departure to become President and CEO of another public, medical technology company, effective today. Hanson was the former Executive Vice President of MITG.

“We are pleased to name Bob White and Chris Lee to these new leadership assignments. Their extensive knowledge and expertise of the Medtronic businesses and regions involved - as well as their demonstrated track records of success - will ensure continuity to our overall business strategies and objectives,” said Omar Ishrak, Chairman and CEO of Medtronic. “Bob is uniquely qualified to take on the MITG role given his prior leadership experience in the former Covidien company and his most recent role as President of our APAC region, where he was responsible for advancing MITG and our three other groups in the region. Chris has strong experience across Asia Pacific, having previously led the operations of several leading pharmaceutical companies in the region. Both Bob and Chris have strong records of delivering results, and I look forward to working with them in their new roles.”

“We thank Bryan for his contributions to Medtronic through the Covidien acquisition, its integration into Medtronic and to its current, solid performance as the Minimally Invasive Therapies Group,” added Ishrak. “We wish him and his family well with his new endeavor.”




X